Technical Analysis for ARBI - Arbios Systems Inc New

Grade Last Price % Change Price Change
D 0.0061 -93.90% -0.0939
ARBI closed down 93.9 percent on Wednesday, March 31, 2021, on approximately normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical ARBI trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
New Uptrend Bullish -93.90%
Jack-in-the-Box Bullish Bullish Swing Setup -93.90%
Calm After Storm Range Contraction -93.90%
Narrow Range Bar Range Contraction -93.90%
Wide Bands Range Expansion -93.90%
Older End-of-Day Signals for ARBI ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Arbios Systems, Inc. (Arbios) is a medical device and cell-therapy company focused on the development of products for the treatment of liver failure. The Company’s lead product candidates under development consist of a extracorporeal blood purification therapy called the SEPET Liver Assist Device and an extracorporeal, bioartificial liver therapy referred to as the HepatAssist Cell-Based Liver Support System that incorporate porcine pig liver cells. In October 2008, Arbios announced that it has sold all its rights and interest in its bioartificial liver system, HepatAssist, to HepaLife Technologies, Inc. On January 9, 2009, Arbios announced that it filed for protection under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware.
Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Health Health Sciences Therapy Product Candidates T Cell Hepatology Liver United States Bankruptcy Court Life Technologies Liver Failure

Is ARBI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.1
52 Week Low 0.0018
Average Volume 20,031
200-Day Moving Average 0.0000
50-Day Moving Average 0.0096
20-Day Moving Average 0.0150
10-Day Moving Average 0.0249
Average True Range 0.0144
ADX 24.15
+DI 47.5238
-DI 50.5253
Chandelier Exit (Long, 3 ATRs ) 0.0568
Chandelier Exit (Short, 3 ATRs ) 0.0450
Upper Bollinger Band 0.0718
Lower Bollinger Band -0.0418
Percent B (%b) 0.42
BandWidth 757.3333
MACD Line 0.0102
MACD Signal Line 0.0051
MACD Histogram 0.0051
Fundamentals Value
Market Cap 305 Thousand
Num Shares 50 Million
EPS -0.02
Price-to-Earnings (P/E) Ratio -0.27
Price-to-Sales 0.00
Price-to-Book 9.48
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0061
Resistance 3 (R3) 0.0061 0.0061 0.0061
Resistance 2 (R2) 0.0061 0.0061 0.0061 0.0061
Resistance 1 (R1) 0.0061 0.0061 0.0061 0.0061 0.0061
Pivot Point 0.0061 0.0061 0.0061 0.0061 0.0061
Support 1 (S1) 0.0061 0.0061 0.0061 0.0061 0.0061
Support 2 (S2) 0.0061 0.0061 0.0061 0.0061
Support 3 (S3) 0.0061 0.0061 0.0061
Support 4 (S4) 0.0061